Login
$COGT
$27.15 -$0.29 (1.06%) After hours

$COGT 8-K/A SEC Filings

Filed On Filing
16 Jun 2022 8-K/A: Entry into a Material Definitive Agreement; Other Events

Cogent Biosciences, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several Underwriters named in Schedule I hereto (the “Underwriters”), for whom Jefferies LLC, Piper Sandler & Co. and Guggenheim Securiti...

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support